Results 141 to 150 of about 1,603,200 (360)

CX3CL1 in Early Detection of Alzheimer's Disease: Plasma Dynamics Across Age and Disease Stages

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Backgrounds Alzheimer's disease (AD) is characterized by amyloid‐beta plaques, tau tangles, and neuroinflammation. C‐X3‐C motif chemokine ligand 1 (CX3CL1, also known as fractalkine), a neuroimmune chemokine implicated in AD pathogenesis, shows inconsistent alterations in plasma/serum across studies.
Ling Wang, Yujie Liu, Fei Li, Xuelin Li, Lanlan Li, Jie Zhang, Yali Xu   +6 more
wiley   +1 more source

Comparative Performance of Creatinine-Based GFR Estimation Equations in Exceptional Longevity: The Rugao Longevity and Ageing Study [Erratum]

Clinical Interventions in Aging, 2020
Wang M, Sun X, Ni L, et al. Clin Interv Aging.  2020;15:733– 742.The authors have advised that the Funding statement was missed on page 741 of the published paper.
Wang M, Sun X, Ni L, Zhang M, Zhang J, Ye G, Jin L, Wang X, Chen J   +8 more
doaj  

Reduction in Renal Relapse and Preservation of Long‐Term Kidney Function After Lupus Low Disease Activity in Patients With Lupus Nephritis

Arthritis Care &Research, EarlyView.
Objective Lupus low disease activity state (LLDAS) is a validated treatment target in systemic lupus erythematosus (SLE), but limited studies have explored the role of LLDAS in lupus nephritis (LN). This study aims to investigate the frequency and predictors of LLDAS attainment and its benefit on LN relapse and renal function preservation in patients ...
Chak Kwan Cheung, Desmond Y. H. Yap, Ka Lai Lee, Philip H. Li, Iris Y. K. Tang, Chak Sing Lau, Shirley C. W. Chan   +6 more
wiley   +1 more source

A Scoping Review on Artificial Intelligence–Supported Interventions for Nonpharmacologic Management of Chronic Rheumatic Diseases

Arthritis Care &Research, EarlyView.
This review summarizes artificial intelligence (AI)‐supported nonpharmacological interventions for adults with chronic rheumatic diseases, detailing their components, purpose, and current evidence base. We searched Embase, PubMed, Cochrane, and Scopus databases for studies describing AI‐supported interventions for adults with chronic rheumatic diseases.
Nirali Shah, Alexis Castellanos, Yen Chen, John Piette, Amy Bucher, Susan Murphy   +5 more
wiley   +1 more source

Progressive Loss of Renal Function Is an Age-Dependent Heritable Trait in Type 1 Autosomal Dominant Polycystic Kidney Disease

, 2005
Andrew D. Paterson, Riccardo Magistroni, Ning He, Kairong Wang, Margaret Johnson, Pamela R. Fain, Elizabeth Dicks, Patrick S. Parfrey, Peter St George‐Hyslop, York Pei   +9 more
openalex   +2 more sources

Hydroxychloroquine Associated With Lower Glomerular Filtration Rate Decline in Lupus Nephritis

Arthritis Care &Research, EarlyView.
Objective Hydroxychloroquine (HCQ) protects kidney function in lupus nephritis (LN) by preventing flares, yet some cohort studies show no significant benefit in kidney function with HCQ. Clarifying these conflicting findings by showing early and long‐term benefits of HCQ on kidney function preservation is critical.
Shivani Garg, Brad Rovin, Brad C. Astor, Tripti Singh, Fauzia Hollnagel, Megan Kuik, Lexie Kolton, Callie Saric, S. Sam Lim, Christie M. Bartels   +9 more
wiley   +1 more source

Albuminuria, Kidney Function, and Cancer Risk in the Community [PDF]

, 2020
Yejin Mok, Shoshana H. Ballew, Yingying Sang, Josef Coresh, Corinne E. Joshu, Elizabeth A. Platz, Kunihiro Matsushita   +6 more
openalex   +1 more source

Improvements in Health‐Related Quality of Life With Treat‐to‐Target Urate‐Lowering Therapy in Gout: A Post Hoc Analysis of a Randomized Multicenter Trial

Arthritis Care &Research, EarlyView.
Objective Although treat‐to‐target urate‐lowering therapy (ULT) is endorsed as best practice in gout management, limited data exist on its impact on health‐related quality of life (HRQoL). We assessed the impact of treat‐to‐target ULT on HRQoL among participants receiving protocolized gout care, identifying factors associated with HRQoL and HRQoL ...
Austin Barry, Bryant R. England, Harlan Sayles, Lindsay N. Helget, Maria Androsenko, Hongsheng Wu, Kaleb Michaud, Bridget Kramer, Jeff A. Newcomb, Mary T. Brophy, Anne Davis‐Karim, Ryan Ferguson, Michael H. Pillinger, Tuhina Neogi, Paul M. Palevsky, James R. O'Dell, Ted R. Mikuls   +16 more
wiley   +1 more source

The effect of intraoperative inosine infusion on transplant outcomes in deceased-donor kidney transplant recipients

Renal Failure
Objectives It is unknown when inosine was first employed as a renoprotective agent in the context of kidney transplantation procedures. However, there is no clinical evidence to support a protective role of inosine.
You Luo, Yang Zhang, Zuofu Tang, Jinhua Zhang, Ning Na, Hengjun Xiao   +5 more
doaj   +1 more source

Supplementary Material for: Effect of an Intensive Weight-Loss Lifestyle Intervention on Kidney Function: A Randomized Controlled Trial

, 2021
Andrés Díaz‐López, Nerea Becerra‐Tomás, V. Ruiz-García, Estefanía Toledo, Nancy Babió, Dolores Corella, Montserrat Fitó, Dora Romaguera, Jesús Vioqué, Alonso-Gómez Á.M., Julia Wärnberǵ, J. Alfredo Martínéz, Lluís Serra‐Majem, Ramón Estruch, Francisco J. Tinahones, José Lapetra, Xavier Pintó, Josep A. Tur, José López‐Miranda, Naomi Cano‐Ibáñez, Miguel Delgado‐Rodríguez, Pilar Matía‐Martín, Lidia Daimiel, J.A. DePaz, Josép Vidal, Clotilde Vázquez, Miguel Ruiz‐Canela, Mònica Bulló, José V. Sorlí, Albert Goday, Miquel Fiol, Manuela García de la Hera, Lucas Tojal‐Sierra, Napoleón Pérez‐Farinós, Zulet M.Á., Almudena Sánchez‐Villegas, Emilio Sacanella, José Carlos Fernández‐García, José Manuel Santos‐Lozano, Miquel Gimenez-Gracia, M. DelMarBibiloni, Javier Díez‐Espino, Carolina Ortega‐Azorín, Olga Castañer, M. Morey, Laura Torres‐Collado, Carolina Sorto-Sánchez, Muñoz M.Á., Emilio Ros, Miguel Ángel Martínez‐González, Jordi Salas‐Salvadó, The PREDIMED-Plus Investigators   +51 more
openalex   +1 more source